| D08341 | |
| D number | D08341 |
| Classification | Drug |
| Name | Perphenazine decanoate; Trilafon dekanoat (TN) |
| Component | - |
| Formula | C31H44ClN3O2S |
| Exact mass | 557.2843 |
| Mol weight | 558.218 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Neuropsychiatric agent DG01905 Phenothiazine antipsychotics DG01478 Dopamine antagonist DG01474 Dopamine D2-receptor antagonist Cyp substrate DG01644 CYP2D6 substrate Cyp inhibitor DG01645 CYP2D6 inhibitor |
| Remark | ATC code: N05AB03 Chemical group: DG00875 |
| Activity | - |
| Disease | - |
| Comment | Phenothiazine derivative |
| Target | DRD2 [HSA:1813] [KO:K04145] |
| Metabolism | - |
| Interaction | |
| Other DBs | CAS: 61120-81-8 PubChem: 96025028 LigandBox: D08341 NIKKAJI: J268.401B |
| KCF data | - |